Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Selecta Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Selecta Biosciences Raises USD38 Million in Series E Financing 12
Selecta Biosciences Raises More than USD20 Million in Venture Financing 14
Selecta Biosciences Raises USD4.4 Million in Venture Financing 16
Selecta Biosciences Raises USD6 Million in Venture Financing 17
Selecta Biosciences Raises USD5.3 Million in Venture Financing 18
Selecta Biosciences Secures US$47 Million In Series D Financing Round 19
Partnerships 21
Selecta Biosciences Enters into Research Agreement with Genethon 21
Selecta Biosciences and Juvenile Diabetes Research Foundation Enter into Co-Development Agreement with Sanofi 22
Juvenile Diabetes Research Foundation Enters Into Research Collaboration With Selecta Biosciences 23
Licensing Agreements 24
Selecta Biosciences Enters into Licensing Agreement with National Cancer Institute 24
Spark Therapeutics Enters into Licensing Agreement with Selecta Biosciences 26
Selecta Biosciences Enters into Licensing Agreement with Massachusetts Eye and Ear Infirmary 28
Selecta Biosciences Enters into Licensing Agreement with 3SBio for Pegsiticase 29
Selecta Biosciences Exercises Option for Licensing Agreement with Sanofi 30
Equity Offering 31
Selecta Biosciences Files Registration Statement to Raise Funds through Public Offering of Shares 31
Selecta Biosciences to Raise USD50 Million in Private Placement of Shares and Warrants 32
Selecta Biosciences to Raise USD5 Million in Private Placement of Shares 33
Selecta Biosciences Raises USD70 Million in IPO 35
Selecta Biosciences Inc – Key Competitors 37
Selecta Biosciences Inc – Key Employees 38
Selecta Biosciences Inc – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 40
Financial Announcements 40
Nov 07, 2017: Selecta Biosciences Announces Third Quarter 2017 Financial Results and Provides Corporate Update 40
Aug 11, 2017: Selecta Biosciences Announces Second Quarter 2017 Financial Results and Provides Corporate Update 43
May 11, 2017: Selecta Biosciences Announces First Quarter 2017 Financial Results and Provides Corporate Update 45
Mar 27, 2017: Selecta Biosciences Announces Fourth Quarter and Year End 2016 Financial Results and Provides Corporate Update 47
Nov 10, 2016: Selecta Biosciences Announces Third Quarter 2016 Financial Results 50
Aug 09, 2016: Selecta Biosciences Announces Second Quarter 2016 Financial Results and Provides Corporate Update 52
Corporate Communications 54
Oct 26, 2017: Selecta Biosciences Announces Important Additions to Senior Leadership Team 54
Aug 01, 2016: Selecta Biosciences Appoints Timothy C. Barabe to Board of Directors 55
Product News 56
Aug 01, 2016: Selecta Biosciences Announces Publication in Nature Nanotechnology Describing Novel Approach for Improving the Efficacy and Safety Profile of Biologic Drugs 56
07/19/2016: Selecta Biosciences Announces Gene Therapy Programs for Two Rare Genetic Metabolic Disorders 57
05/01/2017: Selecta Biosciences Announces Presentations at the 20th Annual Meeting of the American Society of Gene & Cell Therapy 58
Clinical Trials 59
May 15, 2017: Selecta Biosciences Announces New Preclinical Gene Therapy Data at the Annual Meeting of the American Society of Gene & Cell Therapy 59
May 11, 2017: Selecta Biosciences Commences Dosing in Phase 1 Clinical Trial of Nicotine Vaccine for Smoking Cessation and Relapse Prevention 60
Feb 06, 2017: Selecta Biosciences Presents Preclinical Data Regarding SVP-Enabled Celiac Disease Treatment 61
Feb 06, 2017: Selecta Biosciences Presents Preclinical Data Regarding SVP-Enabled Peanut Allergy Therapeutic Vaccine 62
Appendix 63
Methodology 63
About GlobalData 63
Contact Us 63
Disclaimer 63
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Selecta Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Selecta Biosciences Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Selecta Biosciences Raises USD38 Million in Series E Financing 12
Selecta Biosciences Raises More than USD20 Million in Venture Financing 14
Selecta Biosciences Raises USD4.4 Million in Venture Financing 16
Selecta Biosciences Raises USD6 Million in Venture Financing 17
Selecta Biosciences Raises USD5.3 Million in Venture Financing 18
Selecta Biosciences Secures US$47 Million In Series D Financing Round 19
Selecta Biosciences Enters into Research Agreement with Genethon 21
Selecta Biosciences and Juvenile Diabetes Research Foundation Enter into Co-Development Agreement with Sanofi 22
Juvenile Diabetes Research Foundation Enters Into Research Collaboration With Selecta Biosciences 23
Selecta Biosciences Enters into Licensing Agreement with National Cancer Institute 24
Spark Therapeutics Enters into Licensing Agreement with Selecta Biosciences 26
Selecta Biosciences Enters into Licensing Agreement with Massachusetts Eye and Ear Infirmary 28
Selecta Biosciences Enters into Licensing Agreement with 3SBio for Pegsiticase 29
Selecta Biosciences Exercises Option for Licensing Agreement with Sanofi 30
Selecta Biosciences Files Registration Statement to Raise Funds through Public Offering of Shares 31
Selecta Biosciences to Raise USD50 Million in Private Placement of Shares and Warrants 32
Selecta Biosciences to Raise USD5 Million in Private Placement of Shares 33
Selecta Biosciences Raises USD70 Million in IPO 35
Selecta Biosciences Inc, Key Competitors 37
Selecta Biosciences Inc, Key Employees 38
Selecta Biosciences Inc, Subsidiaries 39